Small airways in children with allergic rhinoconjunctivitis: the potential role of a multicomponent nutraceutical.


Journal

Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064

Informations de publication

Date de publication:
11 May 2020
Historique:
received: 28 04 2020
entrez: 19 5 2020
pubmed: 19 5 2020
medline: 30 3 2021
Statut: epublish

Résumé

Allergic rhinitis and asthma are closely linked. A progression from rhinitis to overt asthma is common. FEF25-75 is a spirometry parameter that could reflect small airways patency and could reliably predict early bronchial involvement in allergic rhinitis patients. MEF50 very strongly correlates with FEF25-75. The aim of this study was to evaluate possible spirometry change in two groups of children suffering from AR over time. The first group took a course of a nutraceutical (Lertal®) before the observation (active group, AG); a second one was considered as control (control group, CG). The children were visited at baseline, at the end of the nutraceutical course, and after 1 year. FEV1, FVC, and MEF50 were the primary outcomes. After one year, children in AG had significantly higher MEF50 than CG children (p=0.009). In conclusion, the present study showed that a course with a multicomponent nutraceutical could prevent the MEF50 decline in children with allergic rhinoconjunctivitis.

Identifiants

pubmed: 32420972
doi: 10.23750/abm.v91i2.9641
pmc: PMC7569657
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

350-355

Références

Ann Allergy Asthma Immunol. 2013 Apr;110(4):233-9
pubmed: 23535085
J Allergy Clin Immunol. 2006 Nov;118(5):1105-9
pubmed: 17088136
Allergy. 2019 Mar;74(3):607-610
pubmed: 30362571
Allergy Asthma Proc. 2007 Jan-Feb;28(1):74-8
pubmed: 17390762
Allergy. 2008 Apr;63 Suppl 86:8-160
pubmed: 18331513
Eur Respir J. 2005 Nov;26(5):948-68
pubmed: 16264058
J Allergy Clin Immunol. 2017 Oct;140(4):950-958
pubmed: 28602936
Int Arch Allergy Immunol. 2004 May;134(1):34-40
pubmed: 15051938
Allergy. 2018 Jul;73(7):1369-1382
pubmed: 29178130
Allergy. 2005 Jul;60(7):957-60
pubmed: 15932388
Chest. 2003 Mar;123(3):731-5
pubmed: 12628870
J Allergy Clin Immunol Pract. 2018 Nov - Dec;6(6):2127-2129.e2
pubmed: 29559209
Allergy. 2014 Nov;69(11):1515-21
pubmed: 24958195
J Allergy Clin Immunol. 2010 Sep;126(3):527-34.e1-8
pubmed: 20638110
Am J Rhinol Allergy. 2011 Sep-Oct;25(5):e181-5
pubmed: 22186235
J Allergy Clin Immunol. 2016 Jun;137(6):1709-1716.e6
pubmed: 26688518
Ital J Pediatr. 2019 Jul 18;45(1):84
pubmed: 31319883
BMC Pulm Med. 2015 Jul 31;15:83
pubmed: 26228243
Allergy Asthma Immunol Res. 2012 Jul;4(4):171-7
pubmed: 22754709
J Allergy Clin Immunol. 2018 Feb;141(2):529-538.e13
pubmed: 28689794
Am J Rhinol Allergy. 2011 Mar-Apr;25(2):e72-6
pubmed: 21679504
Ital J Pediatr. 2016 Jan 22;42:9
pubmed: 26796331
J Biol Regul Homeost Agents. 2019 Apr 10;33(2):617-622
pubmed: 30968678
J Allergy Clin Immunol. 2009 Feb;123(2):283-94; quiz 295-6
pubmed: 19203652

Auteurs

Salvatore Leonardi (S)

Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy University . gio.cip@libero.it.

Giuseppe Parisi (G)

Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy University. gio.cip@libero.it.

Maria Papale (M)

Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy University. gio.cip@libero.it.

Anna Maria Zicari (AM)

Pediatrics Department, Umberto I Hospital, Roma, Sapienza University, Roma, Italy. gio.cip@libero.it.

Roberta Olcese (R)

Allergy Center, Istituto Giannina Gaslini, Genoa, Italy. gio.cip@libero.it.

Amelia Licari (A)

Department of Pediatrics, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy. gio.cip@libero.it.

Gianluigi Marseglia (G)

Department of Pediatrics, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy. gio.cip@libero.it.

Giorgio Ciprandi (G)

Allergy Clinic, Villa Montallegro, Genoa, Italy. gio.cip@libero.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH